Related Experiment Video

Updated: Jul 30, 2026

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
12:32

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Published on: September 7, 2021

Risk of chromosomal abnormalities, with emphasis on live-born offspring of young mothers

B B Little1, S M Ramin, B S Cambridge

  • 1Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235-9032, USA.

American Journal of Human Genetics
|November 1, 1995
PubMed

Insights

Maternal age impacts chromosomal abnormality risk. Risks for mothers aged 9-16 were similar to those aged 20-29, showing age is a key factor, not ethnicity.

Area of Science:

  • Obstetrics and Gynecology
  • Medical Genetics
  • Reproductive Health

Background:

  • Maternal age is a known risk factor for chromosomal abnormalities.
  • Previous studies have focused on advanced maternal age, with less data on very young mothers.
  • Understanding these risks across all maternal age groups is crucial for prenatal counseling.

Purpose of the Study:

  • To analyze the relationship between maternal age and the risk of chromosomal abnormalities.
  • To specifically investigate the risks associated with very young maternal age (9-16 years).
  • To determine if ethnicity influences the risk of chromosomal abnormalities in relation to maternal age.

Main Methods:

  • Logistic regression analysis was used to assess maternal age-related risks.
  • Data from over 123,000 deliveries between 1980-1989 were analyzed.
  • Frequencies of chromosomal abnormalities and trisomy syndromes were calculated.

Main Results:

  • The overall frequency of chromosomal abnormalities was 0.12%.
  • Mothers aged 9-16 years had similar risks of chromosomal abnormalities as mothers aged 20-29 years.
  • Chromosomal abnormality risks increased with advancing maternal age and were independent of ethnicity.

Conclusions:

  • Very young maternal age (9-16 years) presents a similar risk for chromosomal abnormalities as maternal age in the 20-29 year range.
  • Maternal age is a significant, independent predictor of chromosomal abnormalities.
  • These findings highlight the importance of considering the full spectrum of maternal age in risk assessment for genetic disorders.

More Related Videos

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...